These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7873059)

  • 1. Production and testing of allergenic extracts for diagnostic and therapeutic use in humans: regulatory considerations.
    De Vries YL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):199-201; discussion 201-2. PubMed ID: 7873059
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory control and standardization of allergenic extracts. Modified extracts.
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1985; (79):311-29. PubMed ID: 3931552
    [No Abstract]   [Full Text] [Related]  

  • 3. French application of the European guidelines for regulation of allergenic extracts.
    de Blay F; Doyen V; Bloch-Morot E; Caillot D; Gayraud J; de Laval A; Thillay A;
    J Allergy Clin Immunol; 2013 May; 131(5):1435-7.e7. PubMed ID: 23375207
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory Control and Standardization of Allergenic Extracts. 7th International Paul-Ehrlich Seminar. Langen, September 7-10, 1993.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):1-321. PubMed ID: 7873049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recombinant allergens: diagnostic use and therapeutic perspectives].
    Pauli G; Deviller P
    Rev Mal Respir; 2000 Feb; 17(1 Pt 2):293-303. PubMed ID: 10902143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical considerations in the establishment of release criteria for allergen vaccines in the USA.
    Slater JE; Gam AA; Solanki MD; Burk SH; May FM; Pastor RW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):47-55; discussion 56. PubMed ID: 11487895
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardized allergen extracts in the United States.
    Slater JE
    Clin Allergy Immunol; 2004; 18():421-32. PubMed ID: 15042927
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality parameters for the production of mite extracts.
    Eraso E; Martínez J; Martínez A; Palacios R; Guisantes JA
    Allergol Immunopathol (Madr); 1997; 25(3):113-7. PubMed ID: 9208047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing and standardizing allergen extracts in Europe.
    Larsen JN; Houghton CG; Løwenstein H; Lombardero M
    Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of allergenic products in the U.S.A.; CBER initiatives.
    Liu DT
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):8-12. PubMed ID: 7873070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of allergen regulations: a manufacturer's opinion.
    Rooke MB
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):27-36; discussion 36-8. PubMed ID: 7873062
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

  • 16. Foreword. Allergen products for diagnosis and therapy: regulation and science.
    Rabin RL; Vieths S; Slater JE
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():1-2. PubMed ID: 24912304
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition of recombinant allergens from bench to clinical application.
    Cromwell O; Suck R; Kahlert H; Nandy A; Weber B; Fiebig H
    Methods; 2004 Mar; 32(3):300-12. PubMed ID: 14962765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principle of homologous groups in regulatory affairs of allergen products--a proposal.
    Lorenz AR; Lüttkopf D; May S; Scheurer S; Vieths S
    Int Arch Allergy Immunol; 2009; 148(1):1-17. PubMed ID: 18698143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
    Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
    Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Housedust mite culture medium: an alternative source for the production of allergenic extracts].
    López RI; Lynch NR; Di Prisco MC; Garcia NM
    Acta Cient Venez; 1996; 47(2):103-9. PubMed ID: 9433826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.